Javascript must be enabled to continue!
Ketofol as induction agent in diabetic patients.
View through CrossRef
Objective: To evaluate the role of ketofol as induction agent in diabetic patients. Study Design: Randomized Control Trial. Setting: Department of Anesthesia, Abwa Medical College, Faisalabad. Period: 01-12-21 to 01-05-22. Material & Methods: Patients after informed consent divided randomly into two groups 25 in each. Group A receiving propofol 1.5 mg/kg and Group B receiving ketofol 1:2 as induction agent. The dose given was 1ml for every 5Kg. Standard 5 parameter monitoring with pulse oximetry, ECG, non invasive BP done starting from preoperative to 2 minutes, 5 minutes and 10 minutes after induction agent given. MAP and HR were monitored. Hemodynamic instability was defined as I) Heart rate >160/min or <50/min. II) MAP>120mmHg or <60 mm Hg. Results: Total 50 patients included in this study. 25 in each group. The results show significant stability in hemodynamics in group B. Conclusion: Ketofol has better hemodynamic stability as induction agent in diabetic patients when used in a 2:1 ratio. This makes it a good choice for this specific patient population.
Independent Medical Trust
Title: Ketofol as induction agent in diabetic patients.
Description:
Objective: To evaluate the role of ketofol as induction agent in diabetic patients.
Study Design: Randomized Control Trial.
Setting: Department of Anesthesia, Abwa Medical College, Faisalabad.
Period: 01-12-21 to 01-05-22.
Material & Methods: Patients after informed consent divided randomly into two groups 25 in each.
Group A receiving propofol 1.
5 mg/kg and Group B receiving ketofol 1:2 as induction agent.
The dose given was 1ml for every 5Kg.
Standard 5 parameter monitoring with pulse oximetry, ECG, non invasive BP done starting from preoperative to 2 minutes, 5 minutes and 10 minutes after induction agent given.
MAP and HR were monitored.
Hemodynamic instability was defined as I) Heart rate >160/min or <50/min.
II) MAP>120mmHg or <60 mm Hg.
Results: Total 50 patients included in this study.
25 in each group.
The results show significant stability in hemodynamics in group B.
Conclusion: Ketofol has better hemodynamic stability as induction agent in diabetic patients when used in a 2:1 ratio.
This makes it a good choice for this specific patient population.
Related Results
Effectiveness of ketofol versus propofol induction on hemodynamic profiles in adult elective surgical patients: A Randomized Controlled Trial
Effectiveness of ketofol versus propofol induction on hemodynamic profiles in adult elective surgical patients: A Randomized Controlled Trial
ABSTRACT
Background:
Most of the time propofol and ketamine have been used as an induction agent in adult surgical patie...
Renal biopsy in diabetic patients: Histopathological and clinical correlations
Renal biopsy in diabetic patients: Histopathological and clinical correlations
Introduction: Diabetes is the leading cause of chronic kidney disease and end-stage kidney disease worldwide. A kidney biopsy in a diabetic patient must be considered when non-diab...
Clinical Knowledge and Practice of “Ketofol” at University of Gondar Comprehensive Specialized Hospital
Clinical Knowledge and Practice of “Ketofol” at University of Gondar Comprehensive Specialized Hospital
Background: Ketamine and propofol in a single syringe are reported to create an admixture used for balancing cardiorespiratory effects during induction of general anesthesia. This ...
GW24-e3068 The risk factors analysis and follow-up study of prehypertensive diabetic patients
GW24-e3068 The risk factors analysis and follow-up study of prehypertensive diabetic patients
Objectives
To analyse the prevalence and risk factors of prehypertension among normal blood pressure diabetic patients. To assess the renal function of prehyperte...
A Comparative Change in Left Ventricular Mass Index on Echocardiography in Hypertensive Diabetic and Non-Diabetic Patients Taking Candesartan
A Comparative Change in Left Ventricular Mass Index on Echocardiography in Hypertensive Diabetic and Non-Diabetic Patients Taking Candesartan
Background: To assess the evolution of the left ventricular mass index on echocardiography in candesartan-treated hypertension individuals with and without diabetes. Study Design: ...
Diabetic Foot in Qatar: A Primary Care Perspective
Diabetic Foot in Qatar: A Primary Care Perspective
Diabetic Foot in QatarA primary care Perspective Introduction Diabetes represents a major public health burden in developing countries, especially the Arabian Gulf region, which is...
SERUM VISFATIN, INSULIN RESISTANCE AND BETA CELL FUNCTION IN TYPE II DIABETIC PATIENTS AND NON-DIABETIC ADULT OFFSPRING WITH POSITIVE PARENTAL HISTORY OF TYPE II DIABETES MELLITUS
SERUM VISFATIN, INSULIN RESISTANCE AND BETA CELL FUNCTION IN TYPE II DIABETIC PATIENTS AND NON-DIABETIC ADULT OFFSPRING WITH POSITIVE PARENTAL HISTORY OF TYPE II DIABETES MELLITUS
Introduction:
Non-diabetic individuals with type II diabetic parents are more susceptible to develop Diabetes. Visfatin; an adipocytokine and an enzyme is linked with glucose...
Comparative Analysis of Hepatocellular Carcinoma Patients with and Without Type 2 Diabetes Mellitus
Comparative Analysis of Hepatocellular Carcinoma Patients with and Without Type 2 Diabetes Mellitus
Purpose of the Study: To evaluate the clinical impact of Type 2 Diabetes Mellitus (T2DM) in patients with Hepatocellular Carcinoma (HCC) in comparison to those without T2DM. Metho...

